VIRAGE

multivirus-specific cytotoxic T-lymphocytes · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIRAGE, covering 2014-09-04 to 2014-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) [Phase 1]